Thursday, July 16 7:30–8:30am
AI-The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Friday, July 17 10:30–11:30am
Friday, July 17 1:30–3pm
Managing Pain in the Real World: Challenging Cases in Pain Management
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Information to come
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Jeffrey Rado, MD, MPH, FAPA
- Information to come
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for AstraZeneca, Boehringer Ingelheim, Corcept, GSK, Haleon, and Novo Nordisk; Speaker for Astellas, Bayer, Janssen, Lilly, and Phathom; Advisor for Abbott and Bausch/SALIX
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.